Lee Ainslie - Maverick Capital
Holding/activity history for Halozyme Therapeutics, Inc. (HALO)
← All HALO superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $38.65–51.57 · VW $45.04i | SEC | |
| 2021 Q1 | 2,711 | <0.01 | Reduce 82.12% | <0.01 | $38.80–56.40 · VW $45.86i | $113,000 | SEC |
| 2020 Q4 | 15,164 | 0.01 | Buy | 0.01 | $25.70–44.53 · VW $35.50i | $648,000 | SEC |
Price snapshot:
Current price$76.11
52-week low$55.64
52-week high$82.26